lomustine

FDA Drug Profile — Gleostine

Drug Details

Generic Name
lomustine
Brand Names
Gleostine
Application Number
NDA017588
Sponsor
NextSource Biotechnology, LLC
NDC Codes
6
Dosage Forms
CAPSULE, GELATIN COATED
Routes
ORAL
Active Ingredients
LOMUSTINE

Indications and Usage

1 INDICATIONS AND USAGE Gleostine is an alkylating drug indicated for the treatment of patients with: Brain tumors, primary and metastatic, following appropriate surgical and/or radiotherapeutic procedures. ( 1 ) Hodgkin's lymphoma in combination with other chemotherapies, following disease progression with initial chemotherapy. ( 1 ) 1.1 Brain Tumors Gleostine is indicated for the treatment of patients with primary and metastatic brain tumors following appropriate surgical and/or radiotherapeutic procedures. 1.2 Hodgkin's Lymphoma Gleostine is indicated as a component of combination chemotherapy for the treatment of patients with Hodgkin's lymphoma whose disease has progressed following initial chemotherapy.